Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis.
Journal: Therapeutic advances in gastroenterology
Published: October 24, 2019
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
Journal: Journal of hepatology
Published: October 17, 2019
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial.
Journal: Hepatology (Baltimore, Md.)
Published: September 09, 2019
Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
Journal: The American journal of gastroenterology
Published: August 30, 2019
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.
Journal: Hepatology (Baltimore, Md.)
Published: December 28, 2018
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 03, 2018
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials.
Journal: Hepatology (Baltimore, Md.)
Published: November 29, 2018
DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis.
Journal: JCI insight
Published: August 03, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
Journal: Hepatology (Baltimore, Md.)
Published: May 31, 2017
Effect of evolocumab on cholesterol synthesis and absorption.
Journal: Journal of lipid research
Published: August 25, 2016
Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome.
Journal: Diabetes, obesity & metabolism
Published: July 05, 2016
Last Updated: 09/26/2026